Pharmaceutical & Pharmacovigilance Reporting

A pharmacovigilance team — whether at a Marketing Authorisation Holder (MAH), a distributor, a generics manufacturer, a contract research organisation, or a specialised PV service provider — processes some of the most regulated and most personally identifying data of any industry. A single adverse event report can contain a patient's age, sex, weight, full medication list, comorbidities, indication, the verbatim description of what went wrong, the reporter's identity (often a healthcare professional), the brand and batch of the suspect product, and the reporter's contact details for follow-up. The data is, by regulation, highly identifying — and the obligation to retain it stretches well beyond a typical product lifecycle.

Schweizerform was built for exactly this kind of channel. Every submission is encrypted in the reporter's browser before it leaves the device. We physically cannot read adverse event reports, product quality complaints, medical information requests, or patient support program safety triggers. Hosting is in Switzerland, the four UI languages (EN / DE / FR / IT) are native — which matters for European MAHs that operate across language regions and for direct patient reporting in the patient's actual language — and retention can be set per form to match GVP / Swissmedic / equivalent obligation windows. This page is for PV leads and quality teams already aware that the standard "web form for AE reporting" leaves more exposure on the table than most QPPVs would defend out loud.

Why Pharmacovigilance Has an Outsized Data-Protection Profile

PV data sits at the intersection of multiple regimes that each carry strict, sometimes conflicting, expectations:

• Patient health data — age, sex, weight, indication, full medication list, comorbidities, verbatim reaction description; even pseudonymised cases are often re-identifiable from context (rare disease, paediatric case, named hospital)
• Reporter identity data — the HCP's name, profession, institution, contact for follow-up; sometimes a competitor-product report from a hospital pharmacist who would prefer not to be visible to the MAH's commercial team
• Direct patient-reported outcomes — patient name, DOB, contact, narrative — increasingly common with patient-direct reporting and patient support programs
• Reporter-as-whistleblower scenarios — off-label use observations, suspected serious AE patterns, quality concerns reported by an HCP outside their institution's official channel
• Long retention obligations — GVP and most national PV regulations require retention for the entire authorised lifetime of the product plus 10 years (or longer); the data outlives most other corporate records
• Multi-stakeholder access — internal PV ops, QA, regulatory, sometimes outsourced case-processing CROs, sometimes the global parent's PV database; every additional party multiplies the controllership question
• Cross-border transfers — global PV databases (often US-headquartered) pull EU/Swiss-collected data into broader regulatory regimes, requiring explicit safeguards under GDPR Chapter V

Most online AE-reporting forms today run on conventional SaaS form tools or on the MAH's web infrastructure with standard at-rest encryption. The provider — whether a generic form vendor or the MAH's web team — can read every word of every submission. So can their staff, their integration partners, anyone who compromises their infrastructure, and any authority that serves a lawful order. For a regulated PV channel, that is a wider exposure surface than the formal data-flow mapping usually shows.

What Changes With Zero-Knowledge Intake in a PV Channel

The technical shift is simple. Reporter data — patient details, reaction narrative, suspect product information, reporter identity — is encrypted in the reporter's browser before transmission. The server stores ciphertext. Only the PV team — using the team's Access Code — can decrypt the submission. The form provider becomes a courier of unreadable data, not a custodian of patient health information or reporter identity.

Where MAHs and PV Service Providers Use Schweizerform

Spontaneous AE intake forms

The flagship use. A structured form covering reporter type (patient / HCP / other), patient details (with appropriate minimisation), suspect product (with batch capture for product-quality cross-flagging), reaction description with seriousness criteria, concomitant medications, medical history, and reporter contact for follow-up. Sized to capture E2B(R3)-relevant fields without overcollecting.

Product Quality Complaint (PQC) intake

Quality complaints frequently overlap with AE reports — a patient reporting that a tablet looked discoloured may also be reporting a reaction. A unified PQC / AE intake form (with branching to capture each as appropriate) keeps the patient-side experience simple and the PV / QA cross-flagging clean on the team side.

Medical Information request intake

Medical Information lines receive enquiries that frequently include unsolicited AE information ("my doctor prescribed X for Y, and I had Z reaction"). A structured intake with explicit AE-trigger questions ensures safety information is captured properly even when the enquiry itself is non-safety. Encrypted intake means the enquirer's identity and clinical context are protected by default.

Patient Support Program safety triggers

PSPs (adherence programs, copay assistance, nurse-educator programs) interact with patients on a regular cadence and routinely surface AE-reportable information. A structured PSP intake with embedded AE / PQC trigger logic ensures the program operator captures and forwards safety data in compliance with the MAH's PV agreement, without exposing the patient's identity to the SaaS form vendor.

Investigator-initiated study and compassionate-use safety reporting

IIS and named-patient / compassionate-use programs operate outside the MAH's primary clinical-trial database but generate safety data the MAH must collect and forward. A dedicated encrypted intake form per program gives the medical-affairs team a clean channel without forcing the investigator to use the central trial EDC.

Literature and signal-detection follow-up forms

When literature surveillance or signal detection identifies a case requiring follow-up, the team often needs to contact the original reporter for additional information. A secure follow-up form sent to the HCP or institution preserves confidentiality of the case and the new information without an email PDF round-trip.

Distributor and partner safety-data exchange forms

MAHs with distribution partners, co-marketing arrangements, or licensing partners must exchange safety data within tight reconciliation windows under their PV agreements. A defined intake form per partner avoids the email PDF problem and produces a clean audit trail for the next PV-agreement audit.

What Reporters, Authorities, and Auditors Actually See

Three audiences notice the difference between a generic SaaS / web form and a zero-knowledge intake form: the reporters who file AE / PQC submissions, the competent authority that may inspect the PV system, and the internal QA / external auditor who tests the PV processes against GVP and the MAH's own SOPs.

Features That Matter for Pharmacovigilance Teams

• End-to-end encryption on every form — patient health data and reporter identity protected by default, no paid upgrade required
• Swiss hosting in Swiss data centres — direct answer to the cross-border transfer question for EU/Swiss-collected reports
• Encrypted file uploads — covers labels of suspect product, packaging photos, lab reports, supporting clinical documents
• Native EN / DE / FR / IT — every label, error, and confirmation in the reporter's language; essential for direct patient reporting where reporter trust drives report completeness
• Conditional logic — branch from AE to PQC where overlapping, trigger seriousness-criteria sub-forms only when a reaction is flagged serious, show pregnancy-exposure follow-up only when relevant
• Retention configurable per form — align to internal PV SOPs, GVP minimums, and Swissmedic / national-equivalent expectations; the system enforces what the SOP states
• Audit logging of administrator actions and submission access — documentation for inspection responses and internal QA
• Multiple administrators with role-scoped access — separate AE intake from PQC intake from MedInfo intake, each visible only to the relevant team
• Mobile-first reporter experience — most patient-direct reports start on a phone, often immediately after the reaction
• No third-party trackers on public forms — the patient's browser is not pinging marketing analytics with their health complaint

Common Objections — and Realistic Answers

"Our global safety database is the system of record — why add another step?"

Schweizerform is not the system of record. It is the intake layer in front of it. The case still flows into the global safety database (Argus, ARISg, Veeva Vault Safety, in-house equivalents) for processing, MedDRA coding, expedited reporting, and PSUR generation. What changes is the intake step: the patient or HCP submits to an encrypted form, the PV team decrypts and enters the case in the safety database, and the form-side copy is retained per SOP and then deleted. The safety database remains exactly what it is today.

"We have a PV vendor — they handle the intake page"

Many MAHs do, and many of those vendors run conventional readable-copy intake forms. Schweizerform can sit alongside or replace that intake layer; the case-processing vendor continues to do their work, just starting from data the form provider could not read at rest. For MAHs reviewing PV vendor relationships under their next contract cycle, this is a useful question to put on the table.

"What about the long retention obligation — does form-side deletion compromise that?"

No. The long retention obligation is on the regulated record (the safety database case), not on the intake-layer copy. The form-side submission can be retained for as long as the SOP requires for source-document reconciliation (typically a defined window after case closure) and then deleted, while the safety database holds the regulated case for the full lifetime-plus-10-years window. This is a standard pattern in PV documentation.

"Can the form support E2B(R3) field structure?"

The form captures structured fields aligned to E2B(R3)-relevant data points (patient demographics, suspect product with batch, reaction description with seriousness, concomitant medications, medical history, reporter information). Direct E2B export is not the form's job — the case is entered into the safety database, where E2B(R3) generation lives. The form's job is to capture clean, structured intake from the reporter without exposing it to a third party in plain text.

"What if we lose the Access Code?"

This is the honest trade-off of zero-knowledge architecture. We support a recovery-key flow: a second key set up in advance and stored separately (typically in the QPPV's safe or split between two senior PV team members). Most teams treat the Access Code with the same procedural rigour as any GxP-relevant credential — formal SOP, two custodians, regular review, change-on-departure rule.

"Patients won't bother with a structured form — they want to email or call"

Direct patient reporters are increasingly digital-native and often prefer a clear web form to an email or call. The form does not replace the phone line for the patients who want to call; it is the alternative for those who do not. In published PV experience, a well-designed web intake increases overall report volume, particularly for non-serious AEs that would otherwise be unreported.

Getting Started in a Pharmacovigilance Function

The Bottom Line

Pharmacovigilance channels collect highly identifying patient health data and reporter identity data, retain it for periods that outlast most other corporate records, and route it through internal teams, external case-processing vendors, and global safety databases. The standard "web form for AE reporting" leaves a readable copy at the intake layer that complicates every conversation with regulators, internal QA, and reporters who would prefer to be confident their report stays inside the regulated workflow.

Schweizerform offers a direct answer at the intake layer: zero-knowledge end-to-end encryption on every form, Swiss hosting, native four-language support, encrypted file uploads sized for the documents PV teams actually receive, and retention configurable to align with PV SOPs. The safety database remains the regulated system of record. The intake layer becomes something the QPPV can defend cleanly — to authorities, to auditors, and to the reporters who depend on the channel.